The Australian e-Health Research Centre, CSIRO, Herston, QLD 4006, Australia.
School of Humanities and Languages, UNSW Sydney, Sydney, NSW 1466, Australia.
Nutrients. 2023 Jul 25;15(15):3304. doi: 10.3390/nu15153304.
Gestational Diabetes Mellitus (GDM) is a common medical complication of pregnancy, which is associated with increased risk of future diabetes. mHealth (mobile health, in this paper applications abbreviated to apps) can facilitate health modifications to decrease future risks. This study aims to understand mHealth app use and preferences among women with past GDM and healthcare professionals (HCP) in Australia. An explorative cross-sectional online survey was disseminated via social media, a national diabetes registry, and professional networks. Descriptive analyses were conducted on valid responses (women with prior GDM: = 1475; HCP: = 75). One third (33%) of women with prior GDM have used health apps, and a further 80% of non-app users were open to using a health app if recommended by their HCP. Over half (53%) of HCPs supported health information delivery via mHealth, although only 14% had recommended a health app to women post-GDM, and lack of knowledge about mHealth apps was common. Health app users reported that they preferred tracking features, while non-users desired credible health and dietary information and plans. Expanding mHealth app use could facilitate healthy behaviours, but endorsement by HCPs is important to women and is still currently lacking.
妊娠期糖尿病（GDM）是一种常见的妊娠医学并发症，与未来发生糖尿病的风险增加有关。移动医疗（移动健康，在本文中简称 apps）可以促进健康改变，降低未来风险。本研究旨在了解澳大利亚既往 GDM 女性和医疗保健专业人员（HCP）对 mHealth 应用程序的使用和偏好。通过社交媒体、国家糖尿病登记处和专业网络发布了一项探索性横断面在线调查。对有效回复进行了描述性分析（既往 GDM 女性：=1475；HCP：=75）。三分之一（33%）的既往 GDM 女性使用过健康应用程序，如果 HCP 推荐，80%的非应用程序使用者愿意使用健康应用程序。超过一半（53%）的 HCP 支持通过 mHealth 传递健康信息，但只有 14%的 HCP 在 GDM 后向女性推荐了健康应用程序，而且对 mHealth 应用程序的了解普遍不足。健康应用程序用户报告说他们更喜欢跟踪功能，而非用户则希望获得可信的健康和饮食信息和计划。扩大 mHealth 应用程序的使用可以促进健康行为，但 HCP 的认可对女性很重要，但目前仍缺乏这种认可。
